跳至主要内容
临床试验/NCT07474753
NCT07474753已完成不适用

Habitual Caffeine Intake Affects the Ergogenicity of Dosing Regimens on Muscular Endurance But Not on Sprint and Cognitive Performance in Men and Women

Northumbria University1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2020年12月4日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
Upper- and Lower-boy muscular endurance

研究概览

简要总结

The impact of caffeine habituation on acute responses to different doses of caffeinated coffee has received minimal attention. This study aimed to investigate the effects of different doses of coffee on physical and cognitive performance in men and women with different levels of daily caffeine consumption. Sixty-nine (35 women) athletes participated in this study, attending 4 experimental visits in a double-blind, randomized, crossover fashion: decaffeinated coffee (PLA), 1.5 mg·kg-1 (LCOF), 3 mg·kg-1 (MCOF) and 6 mg·kg-1 of caffeine (HCOF) from coffee ingestion. Sixty min after coffee consumption, participants performed squat and bench press exercises (1 repetition maximum, 1RM), 60% of 1RM muscular endurance (ME), maximal sprinting, and cognitive performance (CP) was assessed. Participants were allocated into low (LGROUP), moderate (MGROUP), and high (HGROUP) caffeine consumption groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

Supplements were allocated in a randomised order and double-blinding design was implemented by an independent technician who did not take part in the study. The randomisation and blinding were held until the end of the study.

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals
  • Physically active individuals
  • Non-smokers
  • Age between 18 and 30 years
  • Free from respiratory insufficiency
  • Free from cardiovascular disease
  • Free from neuromuscular disorders
  • Free from musculoskeletal injury within the previous 6 months

排除标准

  • Diagnosed cardiovascular disease
  • Neuromuscular disease
  • Current limb injury
  • History of limb injury requiring treatment within the previous 6 months
  • Chronic respiratory disease or treatment for chronic respiratory conditions

研究组 & 干预措施

Low dose caffeine supplementation

Experimental

consuming 0.12 g·kg-1 of decaffeinated coffee + 0.04 g·kg-1 of caffeinated coffee to achieve 1.5 mg·kg-1 of caffeine intake 60-min before the experimental trial.

干预措施: Low Dose Caffeine (LCOF) (Dietary Supplement)

Moderate dose caffeine supplementation

Experimental

Consuming 0.08 g·kg-1 of decaffeinated coffee + 0.08 g·kg-1 of caffeinated coffee to achieve 3 mg·kg-1 of caffeine intake 60-min before the experimental trial.

干预措施: Moderate Dose Caffeine (MCOF) (Dietary Supplement)

High dose caffeine supplementation

Experimental

Consuming 0.16 g·kg-1 of caffeinated coffee to achieve 6 mg·kg-1 of caffeine intake 60-min before the experimental trial.

干预措施: High Dose Caffeine (HCOF) (Dietary Supplement)

Placebo

Experimental

Consuming 0.16 g·kg-1 of decaffeinated coffee 60-min before the experimental trial.

干预措施: Placebo (PLA) (Dietary Supplement)

结局指标

主要结局

Upper- and Lower-boy muscular endurance

时间窗: 60 minutes after caffeine or placebo ingestion (during each experimental trial)

Muscular endurance assessed during bench press and squat exercises using 60% of one-repetition maximum (1RM). Performance expressed as total weight lifted (kg).

Upper- and lower-body strenght

时间窗: 60 minutes after caffeine or placebo ingestion (during each experimental trial)

Maximal dynamic strength assessed using one-repetition maximum (1RM) tests in the squat and bench press exercises (kg).

次要结局

  • Sprint Performance(60 minutes after caffeine or placebo ingestion (during each experimental trial))
  • Cognitive performance(Baseline (before caffeine ingestion) and 60 minutes after caffeine or placebo ingestion.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Ozcan Esen

Assistant Professor

Northumbria University

研究点 (1)

Loading locations...

相似试验